150 related articles for article (PubMed ID: 33154243)
1. Genetic sequencing of influenza A (H1N1) pdm09 isolates from South India, collected between 2011 and 2015 to detect mutations affecting virulence and resistance to oseltamivir.
Nandhini P; Sistla S
Indian J Med Microbiol; 2020; 38(3 & 4):324-337. PubMed ID: 33154243
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterisation of influenza A(H1N1)pdm09 viruses circulating in Assam, Northeast India during 2009-2015.
Biswas D; Dutta M; Sarmah K; Yadav K; Buragohain M; Sarma K; Borkakoty B
Indian J Med Microbiol; 2019; 37(1):42-49. PubMed ID: 31424009
[TBL] [Abstract][Full Text] [Related]
3. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
Tandel K; Sharma S; Dash PK; Parida M
J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
[TBL] [Abstract][Full Text] [Related]
5. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015-2016 season and comparison of HA mutations detected in Turkey since 2009.
Guldemir D; Coskun-Ari FF; Altas AB; Bakkaloglu Z; Unaldi O; Bayraktar F; Korukluoglu G; Aktas AR; Durmaz R
J Med Virol; 2019 Dec; 91(12):2074-2082. PubMed ID: 31389035
[TBL] [Abstract][Full Text] [Related]
8. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
9. Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.
Dia N; Niang MN; Diadhiou SA; Goudiaby DG; Faye A; Kiori D; Bâ M; Michel R; Diop OM
BMC Infect Dis; 2013 Feb; 13():106. PubMed ID: 23442314
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
11. Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017.
Kyaw Win SM; Saito R; Win NC; Lasham DJ; Kyaw Y; Lin N; Thein KN; Chon I; Odagiri T; Thein W; Kyaw LL; Tin OS; Saitoh A; Tamura T; Hirokawa C; Uchida Y; Saito T; Watanabe S; Odagiri T; Kamata K; Osada H; Dapat C; Watanabe H; Tin HH
PLoS One; 2020; 15(3):e0229601. PubMed ID: 32130243
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].
Wang XS; Cai JH; Yao WL; Ge YL; Zhu QR; Zeng M
Zhonghua Er Ke Za Zhi; 2013 May; 51(5):356-61. PubMed ID: 23941842
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic.
Morlighem JÉ; Aoki S; Kishima M; Hanami M; Ogawa C; Jalloh A; Takahashi Y; Kawai Y; Saga S; Hayashi E; Ban T; Izumi S; Wada A; Mano M; Fukunaga M; Kijima Y; Shiomi M; Inoue K; Hata T; Koretsune Y; Kudo K; Himeno Y; Hirai A; Takahashi K; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Kawaoka Y; Hayashizaki Y; Ishikawa T
PLoS One; 2011 Apr; 6(4):e18956. PubMed ID: 21572517
[TBL] [Abstract][Full Text] [Related]
14. Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
Zaraket H; Saito R; Suzuki Y; Baranovich T; Dapat C; Caperig-Dapat I; Suzuki H
J Clin Microbiol; 2010 Apr; 48(4):1085-92. PubMed ID: 20129961
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
[TBL] [Abstract][Full Text] [Related]
16. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
17. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
18. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.
Monamele CG; Munshili Njifon HL; Vernet MA; Njankouo MR; Kenmoe S; Yahaya AA; Deweerdt L; Nono R; Mbacham W; Anong DN; Akoachere JF; Njouom R
PLoS One; 2019; 14(1):e0210119. PubMed ID: 30640922
[TBL] [Abstract][Full Text] [Related]
20. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
